<?xml version="1.0" encoding="utf-8"?><!DOCTYPE article PUBLIC "-//ES//DTD journal article DTD version 5.0.2//EN//XML" "art502.dtd" [<!ENTITY gr1 SYSTEM "gr1" NDATA IMAGE><!ENTITY gr2a SYSTEM "gr2a" NDATA IMAGE><!ENTITY gr2bc SYSTEM "gr2bc" NDATA IMAGE><!ENTITY gr3 SYSTEM "gr3" NDATA IMAGE><!ENTITY gr4 SYSTEM "gr4" NDATA IMAGE>]><article docsubtype="sco" xml:lang="en"><ce:floats xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:figure id="fig1"><ce:label>Fig. 1</ce:label><ce:caption><ce:simple-para>Fluorescence binding studies of Tip(168–187) to wild-type LckSH3 (triangles) and LckSH3(P17G) (squares). The fluorescence signal was detected at 340<ce:hsp sp="0.25"/>nm after excitation at 280<ce:hsp sp="0.25"/>nm. All intensities were normalized to a maximum value of 1. Curves were fitted according to the equation given in Section <ce:cross-ref refid="sec1">2</ce:cross-ref>, and give affinities of 16.80<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.61<ce:hsp sp="0.25"/>μM for LckSH3 and 2.23<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.26<ce:hsp sp="0.25"/>μM for LckSH3(P17G).</ce:simple-para></ce:caption><ce:link locator="gr1"/></ce:figure><ce:figure id="fig2"><ce:label>Fig. 2</ce:label><ce:caption><ce:simple-para>NMR titration experiment showing the changes in the <ce:sup loc="pre">1</ce:sup>H, <ce:sup loc="pre">15</ce:sup>N HSQC spectrum of free LckSH3(P17G) (red) upon gradual addition of Tip(140–191). Resonances belonging to the spectrum after the final step of titration (fivefold molar excess of Tip) are shown in green. Resonances are labelled with the corresponding sequence positions. Start and end point of resonances with intermediate exchange behaviour on the NMR timescale are connected (solid lines). Side-chain NH<ce:inf>2</ce:inf> resonances for glutamine and asparagine are connected (dashed lines).</ce:simple-para></ce:caption><ce:link locator="gr2"/></ce:figure><ce:figure id="fig3"><ce:label>Fig. 3</ce:label><ce:caption><ce:simple-para>Ligand binding region of LckSH3. (A) NMR-based model of the LckSH3–Tip complex (from <ce:cross-ref refid="bib14">[14]</ce:cross-ref>). LckSH3 is shown in space-filled presentation and all atoms which are closer than 5<ce:hsp sp="0.25"/>Å to the ligand are coloured in red. Residues 176–187 of Tip, that are involved in LckSH3 binding, are shown as blue sticks. (B) Schematic presentation of the Tip–LckSH3 complex (same view as in (A)). The site of mutation is marked by an arrow and the three major loops are labelled. Red lines connect the Cα-carbons of residues closer than 5<ce:hsp sp="0.25"/>Å to the ligand that were used to define the binding-competent conformation.</ce:simple-para></ce:caption><ce:link locator="gr3"/></ce:figure><ce:figure id="fig4"><ce:label>Fig. 4</ce:label><ce:caption><ce:simple-para>Dynamics of wild-type LckSH3 (open circles) and LckSH3(P17G) (filled circles) as deduced from NMR spectroscopy and MD simulations. (A) Magnitude of the {<ce:sup loc="pre">1</ce:sup>H} <ce:sup loc="pre">15</ce:sup>N heteronuclear NOE at a nitrogen resonance frequency of 60.8<ce:hsp sp="0.25"/>MHz. Error bars indicate the difference in peak intensity between two reference spectra before and after the experiment. (B) Magnitude of the atomic fluctuations of the backbone atoms (C<ce:sup>α</ce:sup>, C′, N<ce:sup>H</ce:sup>) in LckSH3. Error bars indicate the mean standard deviation over six MD simulations.</ce:simple-para></ce:caption><ce:link locator="gr4"/></ce:figure><ce:figure id="fig5"><ce:label>Fig. 5</ce:label><ce:caption><ce:simple-para>Portion of binding-competent conformations in LckSH3 (left) and LckSH3(P17G) (right). A vertical black bar indicates that all 136 pairwise Cα-distances that define the binding-competent conformation were within a given threshold of 1.0<ce:hsp sp="0.25"/>Å (A) or 0.5<ce:hsp sp="0.25"/>Å (B). The analysis was performed for a total of 4002 conformations (667 from each of the six independent MD simulations). Independent of the tolerance criterion used, the binding-competent conformation was sampled approximately two times more frequent in the mutant (379 vs. 174 times at 1.0<ce:hsp sp="0.25"/>Å tolerance and 42 vs. 21 times at 0.5<ce:hsp sp="0.25"/>Å tolerance).</ce:simple-para></ce:caption><ce:link locator="gr5"/></ce:figure></ce:floats><head><ce:title xmlns:ce="http://www.elsevier.com/xml/common/dtd">A proline to glycine mutation in the Lck SH3-domain affects conformational sampling and increases ligand binding affinity</ce:title><ce:presented xmlns:ce="http://www.elsevier.com/xml/common/dtd">Edited by Gianni Cesareni</ce:presented><ce:author-group xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:author><ce:given-name>Finn</ce:given-name><ce:surname>Bauer</ce:surname><ce:cross-ref refid="fn1"><ce:sup>1</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Heinrich</ce:given-name><ce:surname>Sticht</ce:surname><ce:cross-ref refid="cor1"><ce:sup>⁎</ce:sup></ce:cross-ref><ce:e-address type="email">h.sticht@biochem.uni-erlangen.de</ce:e-address></ce:author><ce:affiliation><ce:textfn>Abteilung Bioinformatik, Institut für Biochemie, Emil-Fischer-Zentrum, Universität Erlangen-Nürnberg, Fahrstr. 17, 91054 Erlangen, Germany</ce:textfn></ce:affiliation><ce:correspondence id="cor1"><ce:label>⁎</ce:label><ce:text>Corresponding author. Fax: +49 9131 8522485.</ce:text></ce:correspondence><ce:footnote id="fn1"><ce:label>1</ce:label><ce:note-para>Present address: Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany.</ce:note-para></ce:footnote></ce:author-group><ce:abstract class="author" xml:lang="en" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>Loop flexibility is discussed as a factor that affects ligand binding affinity of SH3 domains. To test this hypothesis, we designed a mutant in which a proline in the RT-loop of the human Lck SH3-domain is replaced by glycine. The dynamics and ligand binding properties of wild-type and mutant LckSH3 were studied by fluorescence and NMR spectroscopy as well as molecular dynamics simulations. Although the mutated residue does not form direct contacts with the ligand, the mutation increases ligand affinity by a factor of eight. The mutant exhibits increased loop flexibility and enhanced sampling of binding-competent conformations. This effect is expected to facilitate ligand binding itself and might also allow formation of tighter contacts in the complex thus resulting in an increased binding affinity.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords class="keyword" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>SH3 domain</ce:text></ce:keyword><ce:keyword><ce:text>Lck</ce:text></ce:keyword><ce:keyword><ce:text>Ligand affinity</ce:text></ce:keyword><ce:keyword><ce:text>Molecular dynamics</ce:text></ce:keyword><ce:keyword><ce:text>Conformational sampling</ce:text></ce:keyword></ce:keywords></head><body><ce:sections xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section><ce:label>1</ce:label><ce:section-title>Introduction</ce:section-title><ce:para>The Src homology 3 (SH3) domain is one of the most commonly found modular protein domain in eukaryotic genomes and more than 2700 SH3 domains have been identified so far. SH3 domains are relatively short (60–70 residues) noncatalytic protein modules <ce:cross-ref refid="bib1">[1]</ce:cross-ref> whose primary activity is to bind proline-rich ligands containing a consensus sequence xP–x–xP motif that forms a canonical type II polyproline helix <ce:cross-ref refid="bib2">[2]</ce:cross-ref>. For most SH3 domains the ligand-binding site consists of two hydrophobic slots, each occupied by a xP dipeptide, and a third, negatively charged specificity pocket that accommodates an adjacent basic residue of the ligand <ce:cross-refs refid="bib2 bib3">[2,3]</ce:cross-refs>. Thus, upon binding only five core ligand residues contact the SH3 domain of which two are invariant prolines and one is a basic residue, leaving little space for specificity. It was recently shown that additional contacts between variable surface patches of the SH3 domain and ligand residues N-terminal or C-terminal to the core can greatly enhance affinity and specificity <ce:cross-refs refid="bib4 bib5 bib6 bib7 bib8 bib9 bib10">[4–10]</ce:cross-refs>.</ce:para><ce:para>Short peptides which cover only the proline-rich sequence stretch without flanking residues, however, can also differ in their binding specificity – even for closely related SH3 domains. For example, the affinities of a short peptide derived from the herpesviral Tip-protein for the SH3 domains of several Src-family kinases (Lck, Hck, Lyn, Src, Fyn, Yes) differ by almost one order of magnitude, and the highest affinities are found for Lck, Hck and Lyn <ce:cross-ref refid="bib11">[11]</ce:cross-ref>. Similar differences in the binding behaviour have also been noted for the HIV-Nef protein and have been attributed to differences in the flexibility of the RT-loop that forms a part of the ligand binding site <ce:cross-ref refid="bib12">[12]</ce:cross-ref>. Residues R18 and T19 of the RT-loop, which are conserved in Fyn, Src, and Yes form tight intramolecular hydrogen bonds resulting in a stiff loop in FynSH3. In contrast, two substitutions (R18I, T19H) in HckSH3 preclude the hydrogen bonding network from forming. The resulting increased flexibility of the RT-loop was suggested to enhance ligand binding by facilitating the adoption of a binding-competent conformation. In Lck, the substitutions R18S and T19H were suggested to result in a highly flexible RT loop as observed in Hck; however, the presence of P17 is likely to significantly reduce the mobility in this region <ce:cross-ref refid="bib12">[12]</ce:cross-ref>.</ce:para><ce:para>In order to address the question whether the binding affinity of LckSH3 can be enhanced by increasing the flexibility of the RT-loop, we designed a mutant in which P17 of the RT-loop is replaced by glycine. The dynamics and ligand binding properties of wild-type and mutant LckSH3 were studied by fluorescence and NMR spectroscopy as well as molecular dynamics simulations. Our study reveals a significantly increased ligand binding affinity of the mutant which correlates with a slightly increased flexibility of the RT-loop and an enhanced sampling of ligand binding-competent conformations.</ce:para></ce:section><ce:section role="materials-methods" id="sec1"><ce:label>2</ce:label><ce:section-title>Materials and methods</ce:section-title><ce:section><ce:label>2.1</ce:label><ce:section-title>Cloning, expression, and purification of LckSH3(P17G)</ce:section-title><ce:para>Nucleotides comprising the SH3 domain of Lck(P17G) were cloned via PCR from the clone of wild-type LckSH3 <ce:cross-ref refid="bib11">[11]</ce:cross-ref> into the <ce:italic>Bam</ce:italic>HI and <ce:italic>Eco</ce:italic>RI restriction sites of pGEX-4T-1 (Amersham Bioscience) using the oligonucleotides LckSH3_P17G_5′ (GGA GGA GGA TCC CCA CTG CAA GAC AAC ATG GTT ATC GCT CTG CAC AGC TAT GAG GGG TCT CAC GAC GGA GAT CTG GGC) and LckSH3_3′ (GGA GGA GAA TTC AGT TCG CTT TGG CCA CAA AAT TGA AGG GG) (MWG-Biotech, Ebersberg, Germany). The numbering scheme used throughout this paper will refer to the expressed protein, in which P17 corresponds to P74 of full-length Lck. The vector pGEX-LckSH3(P17G) provides an N-terminal glutathion <ce:italic>S</ce:italic>-transferase (GST) affinity tag cleavable with thrombin. Expression and purification of LckSH3(P17G) were performed as described previously for wild-type LckSH3 <ce:cross-ref refid="bib11">[11]</ce:cross-ref>, which has the following sequence (P17 shown in bold): <ce:sup loc="pre">1</ce:sup>GSPLQDNLVI ALHSYE<ce:bold>P</ce:bold>SHD GDLGFEKGEQ LRILEQSGEW WKAQSLTTGQ EGFIPFNFVA KAN<ce:sup>63</ce:sup>. For <ce:sup loc="pre">15</ce:sup>N labelling M9 minimal medium was used with [<ce:sup loc="pre">15</ce:sup>N]-ammonium chloride as the sole nitrogen source.</ce:para></ce:section><ce:section><ce:label>2.2</ce:label><ce:section-title>Tip peptides</ce:section-title><ce:para>For fluorescence studies, a synthetic peptide comprising residues A168–G187 of Tip (sequence: <ce:sup loc="pre">168</ce:sup>ATLDPGMPTPPLPPRPANLG<ce:sup>187</ce:sup>) was purchased from Coring (Gernsheim, Germany). Although the proline-rich core motif of Tip was shown to be sufficient for affine Lck binding, the longer peptide was used to keep consistent with previous studies <ce:cross-ref refid="bib8">[8]</ce:cross-ref>. For undisturbed detection of SH3 fluorescence upon addition of ligand, W170 was replaced by leucine which had been shown previously to have no effect on the binding affinity <ce:cross-ref refid="bib11">[11]</ce:cross-ref>. In addition, the N- and C-terminus of the peptides were acetylated and amidated, respectively, to adjust the propensities in the peptide to those of the intact protein <ce:cross-ref refid="bib13">[13]</ce:cross-ref>. For the NMR titration experiment recombinantly expressed Tip(140–191) was used, that was expressed and purified as described in Bauer et al. <ce:cross-ref refid="bib14">[14]</ce:cross-ref>.</ce:para></ce:section><ce:section><ce:label>2.3</ce:label><ce:section-title>Fluorescence spectroscopy and calculation of binding constants</ce:section-title><ce:para>All fluorescence spectra were measured in a F-4500 fluorescence spectrophotometer (Hitachi, Tokyo, Japan) at an excitation wavelength of 280<ce:hsp sp="0.25"/>nm and an emission wavelength of 340<ce:hsp sp="0.25"/>nm at 291<ce:hsp sp="0.25"/>K. A semi-micro quartz fluorescence cell (light path 10<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>4<ce:hsp sp="0.25"/>mm) with magnetic stirrer was used. Stock solutions of up to 5<ce:hsp sp="0.25"/>mM of synthesized Tip(168–187) were added in small increments to 700<ce:hsp sp="0.25"/>μl of 0.5<ce:hsp sp="0.25"/>μM SH3 domain in 50<ce:hsp sp="0.25"/>mM Tris/HCl, 150<ce:hsp sp="0.25"/>mM NaCl, pH 7.4, and subsequently stirred for 2<ce:hsp sp="0.25"/>min. Afterwards, the fluorescence was recorded for 30<ce:hsp sp="0.25"/>s and averaged. Since the concentration of the SH3 domain was low compared to the ligand, the experimental data were fitted to the standard equation<ce:display><ce:formula><mml:math altimg="si1.gif" xmlns:mml="http://www.w3.org/1998/MathML"><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>F</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">max</mml:mi></mml:mrow></mml:msub><mml:mo>·</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mtext>peptide</mml:mtext><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>D</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mtext>peptide</mml:mtext><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:math></ce:formula></ce:display>where [peptide] gives the final ligand concentration at each measurement point, <ce:italic>F</ce:italic> is the measured protein fluorescence intensity at the particular peptide concentration, and <ce:italic>F</ce:italic><ce:inf>max</ce:inf> is the observed maximal fluorescence intensity of the protein when saturated with the peptide. Nonlinear regression curve fitting was carried out to fit the experimental data to the equation, with <ce:italic>F</ce:italic><ce:inf>max</ce:inf> and <ce:italic>K</ce:italic><ce:inf>D</ce:inf> as fitted parameters. The change in protein concentration that occurred as a result of peptide addition was properly corrected.</ce:para></ce:section><ce:section><ce:label>2.4</ce:label><ce:section-title>NMR spectroscopy</ce:section-title><ce:para>NMR experiments were recorded on a Bruker 600<ce:hsp sp="0.25"/>MHz spectrometer (Bruker, Karlsruhe, Germany) equipped with pulsed field gradients capabilities at 298<ce:hsp sp="0.25"/>K. NMR samples contained 1.2<ce:hsp sp="0.25"/>mM <ce:sup loc="pre">15</ce:sup>N-labeled LckSH3 in 40<ce:hsp sp="0.25"/>mM potassium phosphate and 20<ce:hsp sp="0.25"/>mM sodium chloride, pH 6.4, in H<ce:inf>2</ce:inf>O/D<ce:inf>2</ce:inf>O (9:1). The {<ce:sup loc="pre">1</ce:sup>H}<ce:sup loc="pre">15</ce:sup>N–NOE experiments were recorded using the pulse sequences of Dayie and Wagner <ce:cross-ref refid="bib15">[15]</ce:cross-ref>. The relaxation delay was 4<ce:hsp sp="0.25"/>s, and the proton saturation was performed by 120° high-power pulses with an interpulse delay of 5<ce:hsp sp="0.25"/>ms for the final 3<ce:hsp sp="0.25"/>s of the relaxation delay of the saturation experiment.</ce:para></ce:section><ce:section><ce:label>2.5</ce:label><ce:section-title>MD simulations</ce:section-title><ce:para>Six independent MD simulations using different starting structures were performed for wild-type and mutant LckSH3. The six templates for the wild-type simulation were taken from the set of NMR structures (PDB code: 1H92; <ce:cross-ref refid="bib11">[11]</ce:cross-ref>). For the simulations of the mutant, P17 was replaced by glycine in each of the wild-type templates.</ce:para><ce:para>All molecular dynamics (MD) simulations were performed using the AMBER 7 program <ce:cross-ref refid="bib16">[16]</ce:cross-ref> with the parm99 force field <ce:cross-refs refid="bib17 bib18">[17,18]</ce:cross-refs> and the TIP3P water model <ce:cross-ref refid="bib19">[19]</ce:cross-ref> in a periodic water box with at least 10<ce:hsp sp="0.25"/>Å of solvent around every atom of the solute. An appropriate number of counter ions was added to neutralize the charges of the systems, and the Particle Mesh Ewald summation method <ce:cross-ref refid="bib20">[20]</ce:cross-ref> was employed to calculate the long-range electrostatic interactions. MD simulations were performed using the SHAKE procedure <ce:cross-ref refid="bib21">[21]</ce:cross-ref> to constrain all bonds involving hydrogen atoms. The integration time step of the simulation was 1.5 fs, and a 9.0<ce:hsp sp="0.25"/>Å cutoff was used for the nonbonded interactions. All systems were minimized and equilibrated prior to MD production. First the positions of the solvent atoms were optimized using a steepest descent algorithm, while the solute was restrained by a harmonic function with a force constant of 500<ce:hsp sp="0.25"/>kcal<ce:hsp sp="0.25"/>mol<ce:sup>−1</ce:sup><ce:hsp sp="0.25"/>Å<ce:sup>−2</ce:sup>. Subsequently, the temperature of the system was risen from 50<ce:hsp sp="0.25"/>K to 300<ce:hsp sp="0.25"/>K during 18.75<ce:hsp sp="0.25"/>ps of MD. In the next 18.75<ce:hsp sp="0.25"/>ps, the system was simulated at 300<ce:hsp sp="0.25"/>K and electrostatic interactions were now explicitly included. In the last stage of the preparation phase 37.5<ce:hsp sp="0.25"/>ps MD were simulated in which the harmonic restraints on the solute were gradually removed. Subsequently, 1-ns MD simulations were performed for data collection and structures were saved every 1.5<ce:hsp sp="0.25"/>ps for further analysis. For the visualization and structural analysis of the data, the programs MolMol <ce:cross-ref refid="bib22">[22]</ce:cross-ref>, VMD <ce:cross-ref refid="bib23">[23]</ce:cross-ref>, AMBER <ce:cross-ref refid="bib16">[16]</ce:cross-ref>, and X-PLOR <ce:cross-ref refid="bib24">[24]</ce:cross-ref> were used.</ce:para></ce:section></ce:section><ce:section><ce:label>3</ce:label><ce:section-title>Results and discussion</ce:section-title><ce:section><ce:label>3.1</ce:label><ce:section-title>Ligand binding affinity</ce:section-title><ce:para>The affinity of wild-type and mutant LckSH3 for the proline-rich ligand Tip(168–187) was determined using fluorescence spectroscopy. These experiments revealed that replacement of P17 by glycine actually increases the affinity by almost one order of magnitude from 16.8<ce:hsp sp="0.25"/>μM to 2.2<ce:hsp sp="0.25"/>μM (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref><ce:float-anchor refid="fig1"/>).</ce:para><ce:para>Additional insight into the mode of LckSH3(P17G)–Tip interaction was obtained from a NMR titration experiment using <ce:sup loc="pre">15</ce:sup>N-labeled LckSH3(P17G) (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref><ce:float-anchor refid="fig2"/>). The HSQC-spectrum of LckSH3(P17G) and the magnitude of the chemical shift changes upon Tip addition are highly similar to those of the wild-type system <ce:cross-ref refid="bib11">[11]</ce:cross-ref>. This finding confirms that the overall mode of interaction is not altered by the mutation. Like for the wild-type complex, however, fast and intermediate exchange on the NMR timescale (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>) impeded the determination of a high resolution complex structure.</ce:para><ce:para>Information about the location of the mutation with respect to the ligand binding site was therefore obtained from a NMR-based model of the Tip–Lck complex <ce:cross-ref refid="bib14">[14]</ce:cross-ref> and from the high-resolution three-dimensional structure of the homologous LynSH3–Tip complex <ce:cross-ref refid="bib8">[8]</ce:cross-ref>. Both complex structures reveal that residues H13, Y15, D22, W40, F53, and P55–F58 of LckSH3 form direct contacts with the ligand. In contrast, residue 17 is located in approximately 5<ce:hsp sp="0.25"/>Å distance to the ligand binding site (<ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref><ce:float-anchor refid="fig3"/>), and does not form any van der Waals contacts with the ligand. Thus, the increase in affinity in LckSH3(P17G) must be achieved by an indirect mechanism supporting our hypothesis that this mutation might increase the flexibility of the RT-loop and facilitate the formation of a binding-competent conformation.</ce:para></ce:section><ce:section><ce:label>3.2</ce:label><ce:section-title>Overall dynamics of wild-type and mutant LckSH3</ce:section-title><ce:para>The overall dynamics on a ps–ns timescale was investigated by NMR spectroscopy and molecular dynamics (MD) simulations. Measurement of the {<ce:sup loc="pre">1</ce:sup>H}<ce:sup loc="pre">15</ce:sup>N heteronuclear NOE shows that the overall dynamics of LckSH3 is not affected by the mutation (<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref><ce:float-anchor refid="fig4"/>A). In particular, the dynamics of the secondary structure elements (<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>A; grey bars) is virtually identical in both proteins and is close to the theoretically expected maximum value of 0.83 for native globular proteins at 600<ce:hsp sp="0.25"/>MHz <ce:cross-ref refid="bib25">[25]</ce:cross-ref>.</ce:para><ce:para>The replacement of proline by glycine, however, causes a locally increased protein dynamics as indicated by the lower values of the heteronuclear NOE. The effect is particular evident for the residues C-terminally adjacent to the site of the mutation, which form the tip of the RT-loop. This region contains several residues that interact directly with the ligand – in particular D22 forms an essential salt-bridge to R182 of Tip <ce:cross-refs refid="bib8 bib14">[8,14]</ce:cross-refs>. This local increase in flexibility in the mutant is also reflected in the MD simulations and larger atomic fluctuations are observed in the RT-loop (residues L12–F29) and distal loop (residues L50–G53) (<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>B). The distal loop forms contacts with the RT-loop (<ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref>B) explaining why its dynamics is also affected by the presence of the mutation.</ce:para><ce:para>Generally, the loop flexibility is only moderately increased in the mutant on the ps–ns timescale but this effect might become more pronounced on μs–ms timescales which are not yet accessible by conventional MD techniques. One should, however, also take into account that a highly flexible mutant would experience a large loss of conformational entropy upon ligand binding which would counteract a high binding affinity. Therefore, high affinity mutants are not necessarily expected to be highly flexible. A point, which is more important than the flexibility itself, is the structure of the conformations sampled by the free SH3 domain, since the portion of binding-competent conformations is expected to affect complex association and thereby ligand affinity.</ce:para></ce:section><ce:section><ce:label>3.3</ce:label><ce:section-title>Conformational sampling of wild-type and mutant Lck</ce:section-title><ce:para>According to our original hypothesis, we tested whether the P17G mutation facilitates ligand binding by increasing the portion of binding-competent conformations. For that purpose we defined the binding-competent conformation of LckSH3 based on the model of the Tip–LckSH3 complex (<ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref>B; <ce:cross-ref refid="bib14">[14]</ce:cross-ref>). All residues of LckSH3 which have at least one atom in a distance of less than 5<ce:hsp sp="0.25"/>Å from the ligand were considered relevant to maintain the binding-competent conformation. This criterion applies to residues H13–E16, S18, H19, D22, S37–W41, F53, and P55–F58, thus including those residues directly involved in Tip binding (see above) and some of their adjacent residues. The pairwise distances between the Cα-atoms of the respective residues (136 in total) were used to define the geometry of the binding-competent conformation.</ce:para><ce:para>Subsequently, the LckSH3 conformations sampled during MD simulation were screened for their consistency with these Cα-distances. A total of 4002 conformations (667 from each of the six independent MD simulations) was analyzed for LckSH3 and LckSH3(P17G), respectively (<ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref><ce:float-anchor refid="fig5"/>). A structure was considered as binding-competent, if all 136 pairwise Cα-distances deviated less than 1.0<ce:hsp sp="0.25"/>Å (<ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref>A) or less than 0.5<ce:hsp sp="0.25"/>Å (<ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref>B) from those distances observed in the Tip-LckSH3 complex structure. Independent of the tolerance criterion used, the binding-competent conformation was sampled approximately two times more frequent in the mutant (379 vs. 174 times at 1.0<ce:hsp sp="0.25"/>Å tolerance and 42 vs. 21 times at 0.5<ce:hsp sp="0.25"/>Å tolerance). In order to identify the reasons why the P17G mutation favours the binding competent conformation, the structure of the Tip–LckSH3 complex was analyzed in detail. In the complex, the conformation observed for P17 of the LckSH3 backbone is quite strained (<ce:italic>φ</ce:italic><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>−41°; <ce:italic>ψ</ce:italic><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>143°) for a proline. As a consequence, the <ce:italic>φ</ce:italic>-angle of P17 changes during the simulation sampling energetically more favourable values for the <ce:italic>φ</ce:italic>-angle of approximately −80°, while this effect is observed to a much lesser extent for the mutant.</ce:para><ce:para>Our data shows that the P17G mutation slightly increases the local flexibility and alters the conformational sampling in a way that increases portion of binding-competent conformations in the free LckSH3 domain. This effect is expected to facilitate binding itself and might also allow formation of tighter contacts in the complex thus offering a plausible explanation for the increased binding affinity of the mutant.</ce:para><ce:para>The effect of protein dynamics on the ligand binding properties has been described in the past for numerous systems including thrombin <ce:cross-ref refid="bib26">[26]</ce:cross-ref>, cAMP-dependent protein kinase <ce:cross-ref refid="bib27">[27]</ce:cross-ref>, estrogen receptor <ce:cross-ref refid="bib28">[28]</ce:cross-ref>, aldol reductase <ce:cross-refs refid="bib29 bib30">[29,30]</ce:cross-refs>, thymidylate synthase <ce:cross-ref refid="bib31">[31]</ce:cross-ref>, trypsin <ce:cross-ref refid="bib32">[32]</ce:cross-ref>, and HIV-1 protease <ce:cross-refs refid="bib33 bib34 bib35">[33–35]</ce:cross-refs>.</ce:para><ce:para>Mutants in these proteins, which alter the affinity of ligand binding, frequently affect also protein dynamics. This correlation has been thoroughly investigated by MD simulations for HIV-1 protease, for which numerous mutations are known that decrease ligand binding affinity. At least three of these mutations (E35D, N88S, V82F/I84V) were shown to influence the conformational sampling of the free protease: The E35D and V82F/I84V mutations affect the motions of a loop (‘flap’) which is part of the ligand binding pocket. This loop preferentially adopts a more open conformation in the mutant protease <ce:cross-refs refid="bib33 bib35">[33,35]</ce:cross-refs> thereby distorting the shape of the ligand binding pocket. The N88S mutant alters the hydrogen bonding pattern, and residue D30, which is important for inhibitor binding, is fixed in an intramolecular hydrogen bond with S88, thereby reducing the number of binding-competent conformations <ce:cross-ref refid="bib34">[34]</ce:cross-ref>. Thus, apart from their opposite effect on the ligand affinity itself, these properties of mutant HIV-1 proteases are highly similar to the effect observed for LckSH3(P17G).</ce:para><ce:para>Studies of protein dynamics, however, are not only relevant for understanding the effects that govern the affinity between mutant proteins and known ligands, but might also be helpful for the design of novel ligands that exhibit an increased affinity or specificity. Incorporation of protein plasticity in drug design has already been successfully applied to thymidylate synthase and lead to several specific inhibitors that were missed by conventional docking procedures <ce:cross-ref refid="bib31">[31]</ce:cross-ref>.</ce:para></ce:section></ce:section></ce:sections><ce:acknowledgment xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Acknowledgements</ce:section-title><ce:para>This work was supported by a grant from the Deutsche Forschungsgemeinschaft to H.S. (SFB466, C11). The authors thank Prof. Paul Rösch and Prof. Franz X. Schmid for providing access to NMR and fluorescence spectrometers.</ce:para></ce:acknowledgment></body><tail><ce:bibliography xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>References</ce:section-title><ce:bibliography-sec><ce:bib-reference id="bib1"><ce:label>[1]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>C.J.</ce:given-name><ce:surname>Morton</ce:surname></sb:author><sb:author><ce:given-name>I.D.</ce:given-name><ce:surname>Campbell</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>SH3 domains. Molecular ‘Velcro’</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Biol.</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>615</sb:first-page><sb:last-page>617</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>[2]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>W.A.</ce:given-name><ce:surname>Lim</ce:surname></sb:author><sb:author><ce:given-name>F.M.</ce:given-name><ce:surname>Richards</ce:surname></sb:author><sb:author><ce:given-name>R.O.</ce:given-name><ce:surname>Fox</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>372</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>375</sb:first-page><sb:last-page>379</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>[3]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Feng</ce:surname></sb:author><sb:author><ce:given-name>J.K.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Yu</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Simon</ce:surname></sb:author><sb:author><ce:given-name>S.L.</ce:given-name><ce:surname>Schreiber</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3–ligand interactions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>266</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>1241</sb:first-page><sb:last-page>1247</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>[4]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Feng</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Kasahara</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Rickles</ce:surname></sb:author><sb:author><ce:given-name>S.L.</ce:given-name><ce:surname>Schreiber</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>92</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>12408</sb:first-page><sb:last-page>12415</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>[5]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>M.T.</ce:given-name><ce:surname>Pisabarro</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Serrano</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochemistry</sb:maintitle></sb:title><sb:volume-nr>35</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>10634</sb:first-page><sb:last-page>10640</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>[6]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>M.T.</ce:given-name><ce:surname>Pisabarro</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Serrano</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Wilmanns</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Crystal structure of the abl–SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3–ligand interactions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Mol. Biol.</sb:maintitle></sb:title><sb:volume-nr>281</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>513</sb:first-page><sb:last-page>521</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>[7]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Ghose</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Shekhtman</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Goger</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Ji</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Cowburn</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A novel, specific interaction involving the Csk SH3 domain and its natural ligand</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Struct. Biol.</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>998</sb:first-page><sb:last-page>1004</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>[8]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Bauer</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Schweimer</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Meiselbach</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Hoffmann</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Rosch</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Sticht</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Structural characterization of Lyn–SH3 domain in complex with a herpesviral protein reveals an extended recognition motif that enhances binding affinity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Protein Sci.</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>2487</sb:first-page><sb:last-page>2498</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>[9]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Tran</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Hoffmann</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Wiesehan</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Jonas</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Luge</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Aladag</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Willbold</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Insights into human Lck SH3 domain binding specificity: different binding modes of artificial and native ligands</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochemistry</sb:maintitle></sb:title><sb:volume-nr>44</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>15042</sb:first-page><sb:last-page>15052</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>[10]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Schmidt</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Hoffmann</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Tran</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Stoldt</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Stangler</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Wiesehan</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Willbold</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Solution structure of a Hck SH3 domain ligand complex reveals novel interaction modes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Mol. Biol.</sb:maintitle></sb:title><sb:volume-nr>365</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>1517</sb:first-page><sb:last-page>1532</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>[11]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Schweimer</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Hoffmann</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Bauer</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Friedrich</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Kardinal</ce:surname></sb:author><sb:author><ce:given-name>S.M.</ce:given-name><ce:surname>Feller</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Biesinger</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Sticht</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Structural investigation of the binding of a herpesviral protein to the SH3 domain of tyrosine kinase Lck</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochemistry</sb:maintitle></sb:title><sb:volume-nr>41</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>5120</sb:first-page><sb:last-page>5130</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>[12]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Arold</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>O’Brien</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Franken</ce:surname></sb:author><sb:author><ce:given-name>M.P.</ce:given-name><ce:surname>Strub</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Hoh</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Dumas</ce:surname></sb:author><sb:author><ce:given-name>J.E.</ce:given-name><ce:surname>Ladbury</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochemistry</sb:maintitle></sb:title><sb:volume-nr>37</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>14683</sb:first-page><sb:last-page>14691</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>[13]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Chakrabartty</ce:surname></sb:author><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Doig</ce:surname></sb:author><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Baldwin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Helix capping propensities in peptides parallel those in proteins</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>90</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>11332</sb:first-page><sb:last-page>11336</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>[14]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Bauer</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Hofinger</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Hoffmann</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Rosch</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Schweimer</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Sticht</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Characterization of Lck-binding elements in the herpesviral regulatory Tip protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochemistry</sb:maintitle></sb:title><sb:volume-nr>43</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>14932</sb:first-page><sb:last-page>14939</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>[15]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>K.T.</ce:given-name><ce:surname>Dayie</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Wagner</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Relaxation-rate measurements for 15N–1H groups with pulsed-field gradients and preservation of coherence pathways</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Magn. Reson.</sb:maintitle></sb:title><sb:volume-nr>111</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>121</sb:first-page><sb:last-page>126</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>[16]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Pearlman</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Comput. Phys. Commun.</sb:maintitle></sb:title><sb:volume-nr>91</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>41</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>[17]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>T.E.</ce:given-name><ce:surname>Cheatham</ce:surname><ce:suffix>3rd</ce:suffix></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Cieplak</ce:surname></sb:author><sb:author><ce:given-name>P.A.</ce:given-name><ce:surname>Kollman</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A modified version of the Cornell et al. force field with improved sugar pucker phases and helical repeat</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biomol. Struct. Dyn.</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>845</sb:first-page><sb:last-page>862</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>[18]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>W.D.</ce:given-name><ce:surname>Cornell</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A second generation force field for the simulation of proteins, nucleic acids and organic molecules</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Am. Chem. Soc.</sb:maintitle></sb:title><sb:volume-nr>117</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>5179</sb:first-page><sb:last-page>5197</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>[19]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>W.L.</ce:given-name><ce:surname>Jorgensen</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chandrasekhar</ce:surname></sb:author><sb:author><ce:given-name>J.D.</ce:given-name><ce:surname>Madura</ce:surname></sb:author><sb:author><ce:given-name>R.W.</ce:given-name><ce:surname>Impey</ce:surname></sb:author><sb:author><ce:given-name>M.L.</ce:given-name><ce:surname>Klein</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Comparison of simple potential functions for simulating liquid water</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Chem. Phys.</sb:maintitle></sb:title><sb:volume-nr>79</sb:volume-nr></sb:series><sb:date>1983</sb:date></sb:issue><sb:pages><sb:first-page>926</sb:first-page><sb:last-page>935</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>[20]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Darden</ce:surname></sb:author><sb:author><ce:given-name>D.M.</ce:given-name><ce:surname>York</ce:surname></sb:author><sb:author><ce:given-name>L.G.</ce:given-name><ce:surname>Pedersen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Particle mesh Ewald. An <ce:italic>N</ce:italic>.log(<ce:italic>N</ce:italic>) method for Ewald sums in large systems</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Chem. Phys.</sb:maintitle></sb:title><sb:volume-nr>98</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>10089</sb:first-page><sb:last-page>10092</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>[21]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>J.P.</ce:given-name><ce:surname>Ryckaert</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Ciccotti</ce:surname></sb:author><sb:author><ce:given-name>H.J.C.</ce:given-name><ce:surname>Berendsen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of <ce:italic>n</ce:italic>-alkanes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Comput. Phys.</sb:maintitle></sb:title><sb:volume-nr>23</sb:volume-nr></sb:series><sb:date>1977</sb:date></sb:issue><sb:pages><sb:first-page>327</sb:first-page><sb:last-page>341</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>[22]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Koradi</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Billeter</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Wuthrich</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>MOLMOL: a program for display and analysis of macromolecular structures</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Mol. Graph</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>51</sb:first-page><sb:last-page>55</sb:last-page></sb:pages></sb:host><sb:comment>29–32</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>[23]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Humphrey</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Dalke</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Schulten</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>VMD: visual molecular dynamics</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Mol. Graph</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>33</sb:first-page><sb:last-page>38</sb:last-page></sb:pages></sb:host><sb:comment>27–38</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>[24]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.T.</ce:given-name><ce:surname>Brünger</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>XPLOR, Version 3.1. A System for X-ray Crystallography and NMR</sb:maintitle></sb:title></sb:contribution><sb:host><sb:book><sb:date>1992</sb:date><sb:publisher><sb:name>Yale University Press</sb:name><sb:location>New Haven, CT</sb:location></sb:publisher></sb:book></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib25"><ce:label>[25]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Goodman</ce:surname></sb:author><sb:author><ce:given-name>M.D.</ce:given-name><ce:surname>Pagel</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Stone</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Relationships between protein structure and dynamics from a database of NMR-derived backbone order parameters</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Mol. Biol.</sb:maintitle></sb:title><sb:volume-nr>295</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>963</sb:first-page><sb:last-page>978</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib26"><ce:label>[26]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Engh</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Enzyme flexibility, solvent and ‘weak’ interactions characterize thrombin–ligand interactions: implications for drug design</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Structure</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>1353</sb:first-page><sb:last-page>1362</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib27"><ce:label>[27]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Prade</ce:surname></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Engh</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Girod</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Kinzel</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Huber</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Bossemeyer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Structure</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>1627</sb:first-page><sb:last-page>1637</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib28"><ce:label>[28]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Brzozowski</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Molecular basis of agonism and antagonism in the oestrogen receptor</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>389</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>753</sb:first-page><sb:last-page>758</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib29"><ce:label>[29]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Urzhumtsev</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A ‘specificity’ pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Structure</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>601</sb:first-page><sb:last-page>612</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib30"><ce:label>[30]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Davis</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Teague</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Angew. Chem., Int. Ed. Engl.</sb:maintitle></sb:title><sb:volume-nr>38</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>736</sb:first-page><sb:last-page>749</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib31"><ce:label>[31]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Fritz</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Tondi</ce:surname></sb:author><sb:author><ce:given-name>J.S.</ce:given-name><ce:surname>Finer-Moore</ce:surname></sb:author><sb:author><ce:given-name>M.P.</ce:given-name><ce:surname>Costi</ce:surname></sb:author><sb:author><ce:given-name>R.M.</ce:given-name><ce:surname>Stroud</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Chem. Biol.</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>981</sb:first-page><sb:last-page>995</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib32"><ce:label>[32]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Rauh</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Klebe</ce:surname></sb:author><sb:author><ce:given-name>M.T.</ce:given-name><ce:surname>Stubbs</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Understanding protein–ligand interactions: the price of protein flexibility</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Mol. Biol.</sb:maintitle></sb:title><sb:volume-nr>335</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>1325</sb:first-page><sb:last-page>1341</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib33"><ce:label>[33]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.L.</ce:given-name><ce:surname>Perryman</ce:surname></sb:author><sb:author><ce:given-name>J.H.</ce:given-name><ce:surname>Lin</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>McCammon</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Protein Sci.</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>1108</sb:first-page><sb:last-page>1123</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib34"><ce:label>[34]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Wartha</ce:surname></sb:author><sb:author><ce:given-name>A.H.C.</ce:given-name><ce:surname>Horn</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Meiselbach</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Sticht</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Molecular dynamics simulations of HIV-1 protease suggest different mechanisms contributing to drug resistance</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Chem. Theory Comput.</sb:maintitle></sb:title><sb:volume-nr>1</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>315</sb:first-page><sb:last-page>324</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib35"><ce:label>[35]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Meiselbach</ce:surname></sb:author><sb:author><ce:given-name>A.H.</ce:given-name><ce:surname>Horn</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Harrer</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Sticht</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Insights into amprenavir resistance in E35D HIV-1 protease mutation from molecular dynamics and binding free-energy calculations</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Mol. Model</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>297</sb:first-page><sb:last-page>304</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article>
